FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ESAFOXOLANER
异名/同义词(S)-4-(5-(3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-YL)-N-(2-OXO-2-((2,2,2-TRIFLUOROETHYL)AMINO)ETHYL)-1-NAPHTHAMIDE
1-NAPHTHALENECARBOXAMIDE, 4-((5S)-5-(3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-4,5-DIHYDRO-5-(TRIFLUOROMETHYL)-3-ISOXAZOLYL)-N-(2-OXO-2-((2,2,2-TRIFLUOROETHYL)AMINO)ETHYL)-
4-((5S)-5-(3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDRO-1,2-OXAZOL-3-YL)-N-(2-OXO-2-((2,2,2-TRIFLUOROETHYL)AMINO)ETHYL)NAPHTHALENE-1-CARBOXAMIDE
AFOXOLANER, (S)-
ESAFOXOLANER
ESAFOXOLANER [INN]
ESAFOXOLANER [USAN]
CAS登记号1096103-99-9
物质唯一标识(Unique Ingredient Identifier)46658IQN7V
分子式C26H17ClF9N3O3
国际化合物标识(International Chemical Identifier,InChI)OXDDDHGGRFRLEE-QHCPKHFHSA-N
SMILESc1(ccc(c2ccccc12)C3=NO[C@](C3)(C(F)(F)F)c4cc(cc(c4)C(F)(F)F)Cl)C(=O)NCC(NCC(F)(F)F)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System